A'alda Group Expands with New DCC Animal Hospital Launch in Japan

India Pharma Outlook Team | Wednesday, 20 March 2024

 Animal Hospitals, animal healthcare standards, India Pharma Outlook

A'alda Group, a leading provider of multi-specialty veterinary services, has recently announced the grand opening of its new DCC Animal Hospital in Japan. The Group successfully launched India's first-ever Japanese pet care facility in Gurugram and expanded its operations in Delhi and Noida in 2021.

The state-of-the-art facility in Japan represents a significant milestone in A'alda's global expansion strategy and its commitment to delivering exceptional pet healthcare services worldwide. 

The new DCC Animal Hospital in Japan is a testament to A'alda's innovative approach, featuring modern design, cutting-edge medical equipment, and a seamless experience for pet owners. 

The hospital has been thoughtfully designed to provide a warm and pet-friendly environment, with easy access and digital integration of the processes, aligning with A'alda's global mission across countries.

Establishing these hospitals in Japan is essential to DCC's mission to develop a unified global brand and network of premium pet care facilities. DCC aims to provide a consistently exceptional experience for pet owners at any DCC location worldwide.

Dr. Shinya Watari, the General Director of DCC Animal Hospitals in Japan, said, "This opening of the DCC hospital exemplifies our 'Pet to Partner' philosophy of creating a world where pets and their families can thrive together.

 Moving into Japan is a big step forward for DCC as we continue our mission of safeguarding the lives of animals and people. We are thrilled to present our creative solutions to Japanese pet owners and enhance animal healthcare standards there."

Founder Masamichi Okuda said, "For us, it will be a turning point in our goal towards promoting happiness among animals. We are confident that we will meet pet owners' changing needs and contribute positively to the community by using our expertise and strategic alliances."

© 2024 India Pharma Outlook. All Rights Reserved.